表 3. The influence of hepatitis B virus on the sleep patterns in female patients.

乙型肝炎病毒对女性患者睡眠情况的影响

Group	n	Subjective sleep quality	Sleep onset latency	Actual sleep duration	Sleep efficiency	Sleep disorders	Daytime dysfunction	Hypnotic drug use	PSQI score
ULN: upper limit of normal; PSQI score: Pittsburgh Sleep Quality Index score. * P < 0.05, vs. low replication group; # P < 0.05, vs. medium replication group.
Control	30	0.99 ± 0.09	1.04 ± 0.12	0.95 ± 0.11	0.83 ± 0.09	1.01 ± 0.09	0.95 ± 0.08	0.73 0.11	6.51 ± 0.23
ALT normal
Low replication	33	1.02 ± 0.13	1.03 ± 0.13	0.93 ± 0.10	0.86 ± 0.10	1.00 ± 0.08	0.97 ± 0.10	0.74 ± 0.13	6.56 ± 0.25
Medium replication	34	1.00 ± 0.13	1.04 ± 0.10	0.96 ± 0.09	0.87 ± 0.10	1.02 ± 0.09	0.97 ± 0.09	0.75 ± 0.13	6.62 ± 0.22
High replication	30	1.01 ± 0.13	1.02 ± 0.11	0.93 ± 0.11	0.88 ± 0.13	1.00 ± 0.09	0.96 ± 0.10	0.73 ± 0.16	6.49 ± 0.25
F		0.264	0.944	0.927	0.104	0.744	0.266	0.216	2.019
P		0.768	0.393	0.399	0.901	0.478	0.767	0.806	0.138
ULN ≤ ALT < 2 ULN
Low replication	31	1.23 ± 0.10	1.29 ± 0.13	1.36 ± 0.15	1.18 ± 0.17	1.37 ± 0.18	1.23 ± 0.18	1.02 ± 0.26	8.68 ± 0.47
Medium replication	34	1.19 ± 0.11	1.29 ± 0.12	1.34 ± 0.13	1.15 ± 0.16	1.40 ± 0.17	1.21 ± 0.18	1.02 ± 0.24	8.69 ± 0.47
High replication	34	1.21 ± 0.12	1.29 ± 0.12	1.34 ± 0.11	1.17 ± 0.14	1.36 ± 0.17	1.21 ± 0.15	1.03 ± 0.13	8.62 ± 0.39
F		0.816	0.034	0.180	0.261	0.494	0.119	0.063	0.290
P		0.445	0.967	0.836	0.771	0.612	0.888	0.939	0.749
2 ULN ≤ ALT
Low replication	36	1.52 ± 0.17	1.72 ±0.24	1.56 ± 0.22	1.59 ± 0.23	1.89 ± 0.19	1.58 ± 0.18	1.19 ± 0.23	11.02 ± 0.52
Medium replication	38	1.85 ± 0.23*	1.92 ± 0.22*	1.86 ± 0.19*	1.96 ± 0.18*	2.11 ± 0.19*	1.94 ± 0.21*	1.50 ± 0.23*	13.15 ± 0.48*
High replication	36	2.26 ± 0.34*, #	2.28 ± 0.30*, #	2.23 ± 0.22*, #	2.28 ± 0.26*, #	2.53 ± 0.31*, #	2.33 ± 0.25*, #	2.04 ± 0.28*, #	15.93 ± 0.71*, #
F		77.134	42.870	94.813	84.358	66.774	114.584	108.254	656.544
P		< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001